Consructio Needs Over Next Five Years Total Estimated $696 Million; NCI Share-$132 Million
In Brief: NCAB Still Without New Appinees As Carter, Califano Delay Drags On; Keele to U. Kansas
New Staff Proposals For Comprehensive Center Recognition Considered By NCAB
DCT Announces Neutron Therapy RFP Available
Rall Says NTP to Put 50-75 Chemicals On Long Term Tests
NCAB Subcommittee Worries About Board’s Makeup
Court Forces CPSC To Reopen Carcinogen Policy
Trending Stories
- U.S. News rankings for cancer hospitals shift again with inclusion of Medicare Advantage data
Rankings now include a list of Best Regional Hospitals for Equitable Access - Robert Gallo named founding director of Microbial Oncology Program at TGH Cancer Institute
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Proposed rule by CMS would expand access to cancer treatment at tribal facilities
- A view from the BMT unit on the day a Russian cruise missile hit Kyiv’s Ohmatdyt hospital
- Platinum drugs are off the shortage list, but the underlying problem is unsolved
FDA’s Califf: “We have a market failure due to unwillingness of health systems and cancer centers to pay a fair price.”